Shandong Intco Medical Products Co Ltd
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers gloves; face masks; isolation gown, lab coat/jacket, and scrub suit; aldult and pe… Read more
Shandong Intco Medical Products Co Ltd (300677) - Net Assets
Latest net assets as of September 2025: CN¥18.47 Billion CNY
Based on the latest financial reports, Shandong Intco Medical Products Co Ltd (300677) has net assets worth CN¥18.47 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥39.97 Billion) and total liabilities (CN¥21.50 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥18.47 Billion |
| % of Total Assets | 46.21% |
| Annual Growth Rate | 54.48% |
| 5-Year Change | 87.25% |
| 10-Year Change | 4158.69% |
| Growth Volatility | 147.8 |
Shandong Intco Medical Products Co Ltd - Net Assets Trend (2013–2024)
This chart illustrates how Shandong Intco Medical Products Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shandong Intco Medical Products Co Ltd (2013–2024)
The table below shows the annual net assets of Shandong Intco Medical Products Co Ltd from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥17.68 Billion | +8.51% |
| 2023-12-31 | CN¥16.29 Billion | +1.53% |
| 2022-12-31 | CN¥16.05 Billion | -0.46% |
| 2021-12-31 | CN¥16.12 Billion | +70.75% |
| 2020-12-31 | CN¥9.44 Billion | +528.77% |
| 2019-12-31 | CN¥1.50 Billion | +17.96% |
| 2018-12-31 | CN¥1.27 Billion | +17.06% |
| 2017-12-31 | CN¥1.09 Billion | +116.46% |
| 2016-12-31 | CN¥502.40 Million | +21.01% |
| 2015-12-31 | CN¥415.19 Million | +146.59% |
| 2014-12-31 | CN¥168.38 Million | +13.90% |
| 2013-12-31 | CN¥147.82 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shandong Intco Medical Products Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1553654712458.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥15.53 Billion | 89.22% |
| Common Stock | CN¥646.19 Million | 3.71% |
| Other Comprehensive Income | CN¥-381.47K | 0.00% |
| Other Components | CN¥1.23 Billion | 7.07% |
| Total Equity | CN¥17.40 Billion | 100.00% |
Shandong Intco Medical Products Co Ltd Competitors by Market Cap
The table below lists competitors of Shandong Intco Medical Products Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Voestalpine AG
PINK:VLPNF
|
$3.47 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
$3.47 Billion |
|
CALIFORNA RESOURC. DL-01
F:1CLD
|
$3.47 Billion |
|
Waystar Holding Corp. Common Stock
NASDAQ:WAY
|
$3.47 Billion |
|
DoorDash, Inc.
SA:D2AS34
|
$3.47 Billion |
|
Kyowa Kirin Co. Ltd
PINK:KYKOF
|
$3.46 Billion |
|
The Siam Cement Public Company Limited
PINK:SCVPF
|
$3.46 Billion |
|
Zealand Pharma A/S
PINK:ZLDPF
|
$3.46 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shandong Intco Medical Products Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 16,028,587,817 to 17,404,080,149, a change of 1,375,492,332 (8.6%).
- Net income of 1,465,476,197 contributed positively to equity growth.
- Dividend payments of 338,282,212 reduced retained earnings.
- Share repurchases of 25,834,515 reduced equity.
- Other comprehensive income increased equity by 56,246,009.
- Other factors increased equity by 217,886,853.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.47 Billion | +8.42% |
| Dividends Paid | CN¥338.28 Million | -1.94% |
| Share Repurchases | CN¥25.83 Million | -0.15% |
| Other Comprehensive Income | CN¥56.25 Million | +0.32% |
| Other Changes | CN¥217.89 Million | +1.25% |
| Total Change | CN¥- | 8.58% |
Book Value vs Market Value Analysis
This analysis compares Shandong Intco Medical Products Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.29x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 121.63x to 2.29x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | CN¥0.51 | CN¥61.50 | x |
| 2014-12-31 | CN¥0.58 | CN¥61.50 | x |
| 2015-12-31 | CN¥1.20 | CN¥61.50 | x |
| 2016-12-31 | CN¥1.28 | CN¥61.50 | x |
| 2017-12-31 | CN¥2.42 | CN¥61.50 | x |
| 2018-12-31 | CN¥2.42 | CN¥61.50 | x |
| 2019-12-31 | CN¥2.73 | CN¥61.50 | x |
| 2020-12-31 | CN¥25.35 | CN¥61.50 | x |
| 2021-12-31 | CN¥23.50 | CN¥61.50 | x |
| 2022-12-31 | CN¥23.87 | CN¥61.50 | x |
| 2023-12-31 | CN¥24.27 | CN¥61.50 | x |
| 2024-12-31 | CN¥26.84 | CN¥61.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shandong Intco Medical Products Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.42%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.39%
- • Asset Turnover: 0.27x
- • Equity Multiplier: 1.99x
- Recent ROE (8.42%) is below the historical average (19.58%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 7.32% | 1.50% | 1.01x | 4.82x | CN¥-3.92 Million |
| 2014 | 18.92% | 3.60% | 1.35x | 3.90x | CN¥15.02 Million |
| 2015 | 15.47% | 6.43% | 1.32x | 1.82x | CN¥22.70 Million |
| 2016 | 17.13% | 7.27% | 1.08x | 2.17x | CN¥35.81 Million |
| 2017 | 13.34% | 8.29% | 1.06x | 1.52x | CN¥36.33 Million |
| 2018 | 14.09% | 9.48% | 0.78x | 1.90x | CN¥52.03 Million |
| 2019 | 12.07% | 8.56% | 0.70x | 2.03x | CN¥30.58 Million |
| 2020 | 74.99% | 50.64% | 1.07x | 1.38x | CN¥6.07 Billion |
| 2021 | 46.81% | 45.75% | 0.79x | 1.30x | CN¥5.84 Billion |
| 2022 | 3.98% | 9.51% | 0.31x | 1.36x | CN¥-951.56 Million |
| 2023 | 2.39% | 5.54% | 0.26x | 1.69x | CN¥-1.22 Billion |
| 2024 | 8.42% | 15.39% | 0.27x | 1.99x | CN¥-274.93 Million |
Industry Comparison
This section compares Shandong Intco Medical Products Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shandong Intco Medical Products Co Ltd (300677) | CN¥18.47 Billion | 7.32% | 1.16x | $3.47 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |